Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 5Completed 3Active not recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 2NIH 2INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Thoracic 5

Conditions

Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Stomach Neoplasms 5Lung Neoplasms 5Breast Neoplasms 5Endometrial Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Pancreatic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Obesity 2Meningioma 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Esophageal Neoplasms 2Disease 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Surgical Wound Dehiscence 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Skull Base Neoplasms 1Skin Neoplasms 1Salivary Gland Neoplasms 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 35Cisplatin 26Blood Specimen Collection 25durvalumab 17Paclitaxel 17osimertinib 15Radiosurgery 15Bevacizumab 15Radiotherapy 14Nivolumab 14Gemcitabine 14atezolizumab 13Biopsy 13Drug Therapy 12Docetaxel 11130-nm albumin-bound paclitaxel 11Immunoglobulin G 10X-Rays 9Taxes 9Standard of Care 9Practice Guidelines as Topic 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Observation × Clear all
NCT04267848 2026-05-27

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

National Cancer Institute (NCI)

Phase 3 Recruiting
1,210 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06498635 2026-05-27

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

National Cancer Institute (NCI)

Phase 3 Recruiting
306 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04566432 2024-07-18

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Geneplus-Beijing Co. Ltd.

Recruiting
250 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06448455 2024-06-10

Observation on the Frailty Status of Lung Cancer Patients

Peking University Third Hospital

Recruiting
200 enrolled
Thoracic

Frailty, Lung Neoplasms

NCT05857800 2023-06-08

NAT-LungMate

Shanghai Pulmonary Hospital, Shanghai, China

Recruiting
2,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡